课题基金 / 基金详情

EFFICACY AND SAFETY OF TIBOLONE IN POSTMENOPAUSAL WOMEN

EFFICACY AND SAFETY OF TIBOLONE IN POSTMENOPAUSAL WOMEN
替勃龙对绝经后女性的疗效和安全性
批准号：
5222186
负责人：
JOSEPH MORTOLA
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5222186
关键词：
chemoprevention clinical research clinical trial phase I dosage drug screening /evaluation female hormone therapy human subject human therapy evaluation osteoporosis postmenopause progesterone analog skeletal disorder chemotherapy

项目摘要

项目成果

JOSEPH MORTOLA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To determine the minimum effective dose of Tibolone for prevention of menopausal osteoporosis and to demonstrate the efficacy, safety and acceptability of the medication at the therapeutic dose for this indication.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SAFETY AND EFFICACY OF RECOMBINANT HCG WITH PROFASI IN WOMEN UNDERGOING IVF
EFFICACY AND SAFETY OF TIBOLONE IN POSTMENOPAUSAL WOMEN
EFFICACY AND SAFETY OF 3 DOSES OF ESTERFIED ESTROGENS ON BONE MINERAL METABOLISM
POLYCYSTIC OVARY VARIANTS--PATIENTS WITH NORMAL FSH/LH RATIOS
海外基金